| 1 |
Barbara Pio |
Merck |
3 |
| 1 |
Kumar Mayur Thakur |
Google |
3 |
| 1 |
David Klar |
Trendsformers |
3 |
| #4 |
Benjamin R. Bartfield |
Merck |
2 |
| #4 |
Peter Li |
Cellco Partnership |
2 |
| #4 |
Samuel N. Kamens |
Open Text |
2 |
| #4 |
David Colie Wight |
Helen Of Troy Limited |
2 |
| #4 |
Getachew Kassa |
Henschel-Steinau |
2 |
| #4 |
Treena Arinzeh |
New Jersey Institute Of Technology |
2 |
| #4 |
Panayiotis Stevis |
Regeneron Pharmaceuticals |
2 |
| #11 |
Carline Darcelin-Riley |
American Express |
1 |
| #11 |
Ekaterina Doubrovina |
Memorial Sloan Kettering Cancer Center |
1 |
| #11 |
Douglas Adams |
Flowserve Management |
1 |
| #11 |
Suryansh Agarwal |
Oracle |
1 |
| #11 |
Annamalai Selvakumar |
Memorial Sloan Kettering Cancer Center |
1 |
| #11 |
Richard S. Heyderman |
Mdr |
1 |
| #11 |
Valery A. Sheverev |
Lenterra |
1 |
| #11 |
Stephen Liaci |
— |
1 |
| #11 |
Jeffrey B. Canter |
Bae Systems Information And Electronic Systems Integration |
1 |
| #11 |
Robert Mendelow |
Goldman Sachs |
1 |
| #11 |
Matthew Noesner |
Maquet Cardiovascular |
1 |
| #11 |
Philip A. Band |
New York University |
1 |
| #11 |
Harpreet K. Sandhu |
Hoffmann-La Roche |
1 |
| #11 |
Robert Francis Kester |
Hoffmann-La Roche |
1 |
| #11 |
Vincent A. Miller |
Foundation Medicine |
1 |
| #11 |
James P. Kerns |
— |
1 |
| #11 |
Kurt Ryan Rohloff |
RTX (Raytheon) |
1 |
| #11 |
Daniel Zewge |
Sirna Therapeutics |
1 |
| #11 |
Laird Popkin |
Time Warner |
1 |